Description
Cubosomes have attracted widespread attention in the pharmaceutical industry due to their high stability, ability to contain amphiphilic drugs, controlled drug delivery and biocompatibility. The aim of this research is to develop a new thiolated polymer, cysteine-polyethylene glycol stearate (Cys-EG-SA) for the assembling of cubsomes, named Cys-cubosomes. In this project, candidates will be able to prepare Cys-cubosomes and characterize the particle size, zeta potential, morphology and nanostructure using various techniques. The cellular uptake and cytotoxicity of Cys-cubosomes will be evaluated by in vitro and in vivo experiments.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
drug delivery, nanoparticles
School
Biomedicine Discovery Institute (School of Biomedical Sciences) » Biochemistry and Molecular Biology
Available options
PhD/Doctorate
Masters by research
Time commitment
Full-time
Part-time
Physical location
15 Innovation Walk